A detailed history of Cutler Group LP transactions in Fibrogen Inc stock. As of the latest transaction made, Cutler Group LP holds 900 shares of FGEN stock, worth $432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
900
Previous 3,400 73.53%
Holding current value
$432
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$0.73 - $2.73 $1,825 - $6,825
-2,500 Reduced 73.53%
900 $2,000
Q3 2023

Nov 07, 2023

SELL
$0.79 - $2.83 $5,688 - $20,376
-7,200 Reduced 67.92%
3,400 $2,000
Q2 2023

Jul 18, 2023

BUY
$2.49 - $20.59 $20,169 - $166,779
8,100 Added 324.0%
10,600 $28,000
Q1 2023

May 01, 2023

SELL
$15.95 - $25.18 $22,330 - $35,252
-1,400 Reduced 35.9%
2,500 $46,000
Q4 2022

Feb 07, 2023

SELL
$13.27 - $17.73 $1,327 - $1,773
-100 Reduced 2.5%
3,900 $62,000
Q2 2022

Aug 04, 2022

SELL
$7.94 - $12.96 $10,480 - $17,107
-1,320 Reduced 24.81%
4,000 $42,000
Q1 2022

Apr 14, 2022

SELL
$12.02 - $16.79 $320,958 - $448,326
-26,702 Reduced 83.39%
5,320 $63,000
Q4 2021

Jan 18, 2022

BUY
$9.93 - $15.39 $237,614 - $368,267
23,929 Added 295.68%
32,022 $451,000
Q3 2021

Oct 26, 2021

BUY
$10.18 - $26.64 $21,378 - $55,944
2,100 Added 35.04%
8,093 $82,000
Q2 2021

Jul 19, 2021

BUY
$18.57 - $35.68 $92,720 - $178,150
4,993 Added 499.3%
5,993 $159,000
Q1 2020

May 07, 2020

SELL
$23.3 - $45.96 $226,732 - $447,236
-9,731 Reduced 90.68%
1,000 $34,000
Q4 2019

Feb 06, 2020

BUY
$34.58 - $48.06 $314,020 - $436,432
9,081 Added 550.36%
10,731 $460,000
Q3 2019

Oct 28, 2019

BUY
$36.98 - $48.45 $57,318 - $75,097
1,550 Added 1550.0%
1,650 $61,000
Q2 2019

Aug 09, 2019

SELL
$35.13 - $55.53 $145,789 - $230,449
-4,150 Reduced 97.65%
100 $4,000
Q1 2019

May 10, 2019

SELL
$42.83 - $59.91 $115,641 - $161,757
-2,700 Reduced 38.85%
4,250 $230,000
Q4 2018

Feb 05, 2019

BUY
$37.97 - $60.16 $233,515 - $369,984
6,150 Added 768.75%
6,950 $321,000
Q2 2018

Aug 10, 2018

BUY
$44.9 - $64.95 $13,470 - $19,485
300 Added 60.0%
800 $50,000
Q1 2018

May 11, 2018

SELL
$45.35 - $61.65 $439,396 - $597,326
-9,689 Reduced 95.09%
500 $23,000
Q4 2017

Jan 17, 2018

SELL
$41.95 - $60.1 $394,833 - $565,661
-9,412 Reduced 48.02%
10,189 $482,000
Q3 2017

Oct 17, 2017

BUY
$33.4 - $53.9 $654,673 - $1.06 Million
19,601
19,601 $1.05 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $45M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.